Loki Home

Research Interests

Funding Opportunities

FAQ

UI Login Guest Login

Browse by Investigator Last Name



Browse Research


Photo of David  Bushnell, Jr.

David L. Bushnell, Jr.

Professor,  Radiology

Contact Information


3811 JPP
Iowa City, IA 52242

Phone:
Email: david-bushnell@uiowa.edu
Web:

Education

MD, Medicine, University of Illinois Abraham Lincoln School of Medicine, Chicago, IL
Residency, Internal Medicine, Lutheran General Hospital, University of Illinois, affiliate Park Ridge, IL
Residency, Nuclear Medicine, University of Wisconsin Hospital & Clinics, Madison, WI

Appointments

Primary: Radiology

Centers and Program Affiliations


Research Interests


MeSH Terms from Publications

Humans, Tomography, Emission-Computed, Radiopharmaceuticals, Tomography, Emission-Computed, Single-Photon, Male, Iodine Radioisotopes, Middle Aged, Neuroendocrine Tumors, Organotechnetium Compounds, Aged, Lung Neoplasms, Cerebral Infarction, Sensitivity and Specificity, Technetium Tc 99m Medronate, Octreotide, Female, Technetium, Adult, 3-Iodobenzylguanidine, Organophosphorus Compounds, Prostatic Neoplasms, Iofetamine, Organometallic Compounds, Fluorodeoxyglucose F18, Technetium Tc 99m Exametazime

Research Summary

  1. Targeted Radioisotope therapy using radiolabeled SSTR peptides
  2. Dosimetric approaches to treatment of thyroid cancer with I-131
  3. Radioimmunotherapy in patients with NHL
  4. Targeted Radioisotope therapy using I-131 MIBG


Recent Publications


Show publications
  1. Bushnell, D, Baum, R. Standard imaging techniques for neuroendocrine tumors. Endocrinol Metab Clin North Am 40(1):153-62, ix, 2011. [PubMed]
  2. Boudreaux, J, Klimstra, D, Hassan, M, Woltering, E, Jensen, R, Goldsmith, S, Nutting, C, Bushnell, D, Caplin, M, Yao, J. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas 39(6):753-66, 2010. [PubMed]
  3. Kulke, M, Anthony, L, Bushnell, D, de Herder, W, Goldsmith, S, Klimstra, D, Marx, S, Pasieka, J, Pommier, R, Yao, J, Jensen, R. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39(6):735-52, 2010. [PubMed]
  4. Bushnell, D, O'Dorisio, T, O'Dorisio, M, Menda, Y, Hicks, R, Van Cutsem, E, Baulieu, J, Borson-Chazot, F, Anthony, L, Benson, A, Oberg, K, Grossman, A, Connolly, M, Bouterfa, H, Li, Y, Kacena, K, LaFrance, N, Pauwels, S. 90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol 28(10):1652-9, 2010. [PubMed]
  5. Besse, I, Madsen, M, Bushnell, D, Juweid, M. Modeling combined radiopharmaceutical therapy: a linear optimization framework. Technol Cancer Res Treat 8(1):51-60, 2009. [PubMed]
  6. Sartor, O, Reid, R, Bushnell, D, Quick, D, Ell, P. Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain. Cancer 109(3):637-43, 2007. [PubMed]
  7. Madsen, M, Bushnell, D, Juweid, M, Menda, Y, O'Dorisio, M, O'Dorisio, T, Besse, I. Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model. J Nucl Med 47(4):660-7, 2006. [PubMed]
  8. Squires, S, Bushnell, D, Menda, Y, Graham, M. Comparison of cardiac to hepatic uptake of 99mTc-tetrofosmin with and without adenosine infusion to predict the presence of haemodynamically significant coronary artery disease. Nucl Med Commun 26(6):513-8, 2005. [PubMed]
  9. Bushnell, D, Menda, Y, Madsen, M, Link, B, Kahn, D, Truhlar, S, Juweid, M, Shannon, M, Murguia, J. 99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma. Nucl Med Commun 25(8):839-43, 2004. [PubMed]
  10. Menda, Y, O'Dorisio, T, Floresca, J, Bushnell, DL, Juweid, M, Graham, MM. Detection of primary and recurrent carcinoid tumors with F-18FDG PET: Comparison with In-111 pentetreotide.. JOURNAL OF NUCLEAR MEDICINE 44(5):72P-73P, MAY 2003.